Response to PCV13 vaccination in patients with multiple myeloma versus healthy controls

Infections are a major cause of morbidity and mortality in individuals with multiple myeloma (MM). These individuals exhibit humoral dysfunction and show a suboptimal response to pneumococcal polysaccharide vaccine (PPV23). Since pneumococcal conjugate vaccine (PCV13) elicits a T cell dependent resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, S. Shahzad, Shah, Deep, Bress, Jonathan, Jamshed, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422465/
https://www.ncbi.nlm.nih.gov/pubmed/30303441
http://dx.doi.org/10.1080/21645515.2018.1534516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422465/
https://www.ncbi.nlm.nih.gov/pubmed/30303441
http://dx.doi.org/10.1080/21645515.2018.1534516

Ejemplares similares